dr. gabor somorjai, Professor of Chemistry, University of California, Berkeley
Dr. Somorjai is a leading researcher in the field of surface chemistry and catalysis. For his contributions to the field, Somorjai won the Wolf Prize in Chemistry in 1998, the Linus Pauling Award in 2000, the National Medal of Science in 2002, and the Priestley Medal in 2008. Dr. Somorjai was elected to the National Academy of Sciences in 1979 and the American Academy of Arts and Sciences in 1983.
dr. cornelia dekker, Medical Director of Stanford-LPCH Vaccine Program, Stanford's School of Medicine
Dr. Dekker specializes in immunology and has had 12 years of clinical vaccine industry experience before coming to Stanford. She currently serves as the IRB Reviewer for Stanford Administrative Panel on Human Subjects in Medical Research. A recipient of the 2008 Excellence in Teaching at Stanford's School of Medicine, Dr. Cornelia completed her internship, residency and fellowship at Duke University Medical School.
dr. jennifer walske, Director of Social Entrepreneurship, University of California, Berkeley
Dr. Walske co-founded Myriad Investments, LLC in 2000 and currently serves as a Managing Director. She is a member of the Academy of Management and a member of the National Venture Capital Association. A recipient of the Earl F. Cheit Outstanding Teaching Award at the Haas School of Business, Dr. Walske was also ranked second in research excellence worldwide by the Institutional All American in Technical Software in 1999.
dr. brent hamaoka, Postdoc at University of California, San Diego
Dr. Hamaoka has over 11 years of research experience in biochemistry including 5 years as a postdoctoral scholar in the Department of Chemistry and Biochemistry at University of California, San Diego . He has previously held positions as a Biomedical Scientist at Lawrence Livermore National Laboratory. Dr. Hamaoka received his PhD from Johns Hopkins University and BS from University of California, Davis.